Company Filing History:

12 out of 4,770

Merck + Co., Inc.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 1991-2010

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7728141 - Substituted naphthyridinone derivatives (2010-06-01),

2. 7576239 - Substituted amides (2009-08-18),

3. 7348456 - Substituted amides (2008-03-25),

4. 5359096 - Cholesterol lowering compounds (1994-10-25),

5. 5317031 - Cholesterol lowering compounds (1994-05-31),

6. 5250563 - Inhibitors of HIV protease (1993-10-05),

7. 5215900 - Microbial transformation of a substituted pyridinone using streptomyces (1993-06-01),

8. 5194379 - Microbial transformation process for the preparation of hydroxylanol (1993-03-16),

9. 5185251 - Microbial transformation of a substituted pyridinone using (1993-02-09),

10. 5132216 - Microbial transformation process for antihypertensive products (1992-07-21),

11. 5085992 - Microbial transformation process for antihypertensive products (1992-02-04),

12. 5066586 - Process for preparation of novel angiotensin II antagonists (1991-11-19),

13. 5057522 - Anti-hypersensitive N2-tetrazole-.beta.-glucuronide analog (1991-10-15),

Certainly! Here's an article about inventor George A Doss:

Title: Exploring the Innovations of George A Doss

Introduction:

George A Doss, a prolific inventor based in Westfield, NJ, has made significant contributions to the field of pharmacology with his groundbreaking patents. With a total of 13 patents to his name, Doss has revolutionized the medical landscape with his inventive compounds.

Latest Patents:

Doss's latest patents include Substituted Naphthyridinone Derivatives, which serve as antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor. These compounds have shown promise in treating a wide array of conditions, ranging from psychosis to movement disorders. Additionally, his work on Substituted Amides has further expanded the potential applications of CB1 receptor modulation in various diseases.

Career Highlights:

Having worked at esteemed companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation, Doss has honed his craft and brought his inventive ideas to fruition. His dedication to research and development has led to the successful patenting of compounds that have the potential to transform patient care.

Collaborations:

Throughout his career, Doss has collaborated with industry experts such as Shieh-Shung T Chen and John G MacConnell. These collaborations have fostered a culture of innovation and knowledge-sharing, leading to the development of pioneering pharmaceutical solutions.

Conclusion:

In conclusion, George A Doss stands as a beacon of innovation in the pharmaceutical industry. His patents reflect a deep understanding of pharmacological mechanisms and a commitment to improving the lives of patients worldwide. Doss's inventive spirit continues to inspire future generations of inventors and researchers in the quest for better healthcare solutions.

If you need more information or have any other requests, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.